Integra Adds Depth to Neurosurgery Unit with Rebound Deal

Integra LifeSciences is gaining a new minimally invasive platform for neurosurgery through its acquisition of Rebound Therapeutics. The Plainsboro, NJ-based company did not disclose the financial terms of the deal. Rebound Therapeutics develops single-use medical devices that enable minimally invasive access, using optics and illumination, for visualization, diagnostic, and therapeutic use in neurosurgery. “The acquisition of Rebound Therapeutics reflects Integra’s ongoing commitment to developing innovative products to address unmet needs in neurosurgery,” Dan Reuvers, corporate VP and president of Integra LifeSciences’ Codman Specialty Surgical division said in a release. “Rebound’s MIS technological platform is a natural addition to our portfolio of neurosurgical products and will expand our therapeutic-focused offerings. We are eager to further develop Rebound’s cutting-edge MIS technologies to help surgeons improve the standard of care for neurosurgery patients.” Integra dipping its feet into the M&A waters shouldn’t come as a surprise. During a July earnings call, Glenn Coleman, Corporate VP, and COO, of Integra indicated that acquisitions could be on the horizon. “We maintain a strong and flexible balance sheet with cash and cash equivalents of $176 million and capacity on our revolver of...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news